Search for other papers by Ingeborg Brønstad in
Google Scholar
PubMed
Search for other papers by Lars Breivik in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Paal Methlie in
Google Scholar
PubMed
Search for other papers by Anette S B Wolff in
Google Scholar
PubMed
Search for other papers by Eirik Bratland in
Google Scholar
PubMed
Search for other papers by Ingrid Nermoen in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Kristian Løvås in
Google Scholar
PubMed
Department of Clinical Science, Department of Medicine, Division of Medicine, University of Bergen, 5021 Bergen, Norway
Search for other papers by Eystein S Husebye in
Google Scholar
PubMed
Introduction The CYP21A2 gene encodes the enzyme steroid 21-hydroxylase (21OH), which is essential for steroid synthesis in the adrenal cortex. Mutations in CYP21A2 are the main cause of the autosomal recessive disorder congenital adrenal
Department of Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria
Search for other papers by Stefan Riedl in
Google Scholar
PubMed
Search for other papers by Friedrich-Wilhelm Röhl in
Google Scholar
PubMed
Search for other papers by Walter Bonfig in
Google Scholar
PubMed
Search for other papers by Jürgen Brämswig in
Google Scholar
PubMed
Search for other papers by Annette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Susanne Fricke-Otto in
Google Scholar
PubMed
Search for other papers by Markus Bettendorf in
Google Scholar
PubMed
Search for other papers by Felix Riepe in
Google Scholar
PubMed
Search for other papers by Gernot Kriegshäuser in
Google Scholar
PubMed
Search for other papers by Eckhard Schönau in
Google Scholar
PubMed
Search for other papers by Gertrud Even in
Google Scholar
PubMed
Search for other papers by Berthold Hauffa in
Google Scholar
PubMed
Search for other papers by Helmuth-Günther Dörr in
Google Scholar
PubMed
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Search for other papers by Klaus Mohnike in
Google Scholar
PubMed
Search for other papers by the AQUAPE CAH Study Group in
Google Scholar
PubMed
Introduction Congenital adrenal hyperplasia (CAH; incidence 1 in 10–15,000) due to 21-hydroxylase deficiency (21-OH) ( CYP21A2 ; OMIM 201910) is an autosomal recessive disorder resulting in a deficient production of the steroid hormones
Search for other papers by Heike Hoyer-Kuhn in
Google Scholar
PubMed
Search for other papers by Angela Huebner in
Google Scholar
PubMed
Search for other papers by Anette Richter-Unruh in
Google Scholar
PubMed
Search for other papers by Markus Bettendorf in
Google Scholar
PubMed
Search for other papers by Tilman Rohrer in
Google Scholar
PubMed
Search for other papers by Klaus Kapelari in
Google Scholar
PubMed
St.Anna Kinderspital, Medical University of Vienna, Vienna, Austria
Search for other papers by Stefan Riedl in
Google Scholar
PubMed
Search for other papers by Klaus Mohnike in
Google Scholar
PubMed
Search for other papers by Helmuth-Günther Dörr in
Google Scholar
PubMed
Search for other papers by Friedrich-Wilhelm Roehl in
Google Scholar
PubMed
Search for other papers by Katharina Fink in
Google Scholar
PubMed
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
Search for other papers by Joachim Woelfle in
Google Scholar
PubMed
Introduction Classic congenital adrenal hyperplasia (CAH) is a hereditary autosomal recessive condition affecting adrenal steroidogenesis. Most of the cases (90–95%) are caused by mutations in the 21-hydroxylase gene ( CYP21A2 ) leading to
Search for other papers by Qiuli Liu in
Google Scholar
PubMed
Search for other papers by Lin-ang Wang in
Google Scholar
PubMed
Search for other papers by Jian Su in
Google Scholar
PubMed
Search for other papers by Dali Tong in
Google Scholar
PubMed
Search for other papers by Weihua Lan in
Google Scholar
PubMed
Search for other papers by Luofu Wang in
Google Scholar
PubMed
Search for other papers by Gaolei Liu in
Google Scholar
PubMed
Search for other papers by Jun Zhang in
Google Scholar
PubMed
AmCare Genomics Lab, Guangzhou, People’s Republic of China
Search for other papers by Victor Wei Zhang in
Google Scholar
PubMed
Search for other papers by Dianzheng Zhang in
Google Scholar
PubMed
Search for other papers by Rongrong Chen in
Google Scholar
PubMed
Search for other papers by Qingyi Zhu in
Google Scholar
PubMed
Search for other papers by Jun Jiang in
Google Scholar
PubMed
. Six cytochrome P450 (CYP) enzymes including CYP11A1, CYP11B1, CYP11B2, CYP17A1, CYP19A1 and CYP21A2 are involved in the synthesis of steroid hormones. Although deficiencies of any of these enzymes can result in CAH ( 3 ), CYP21A2 deficiency (21OHD
Search for other papers by Mirjana Kocova in
Google Scholar
PubMed
Search for other papers by Vesna Janevska in
Google Scholar
PubMed
Search for other papers by Violeta Anastasovska in
Google Scholar
PubMed
. The usual age at diagnosis is 20–40 years with a variable prevalence reaching up to 94% ( 4 , 5 , 6 , 7 ). Some recent studies show that it can also affect younger boys ( 8 ). Severe CYP21A2 gene mutations, late diagnosis, non-compliance and
Search for other papers by Sarmistha Banerjee in
Google Scholar
PubMed
Search for other papers by Allison M Hayes in
Google Scholar
PubMed
Search for other papers by Bernard H Shapiro in
Google Scholar
PubMed
in the MSG-treated rats. (Neonatal and subsequent adult circulating GH profiles resulting from all the present treatments have been reported elsewhere ( 6 , 21 , 23 ).) In this regard, a minimal baseline level of hepatic CYP2C11 (~20 to 40% of
Search for other papers by Piera Rizzolo in
Google Scholar
PubMed
Search for other papers by Valentina Silvestri in
Google Scholar
PubMed
Search for other papers by Virginia Valentini in
Google Scholar
PubMed
Search for other papers by Veronica Zelli in
Google Scholar
PubMed
Search for other papers by Agostino Bucalo in
Google Scholar
PubMed
Search for other papers by Ines Zanna in
Google Scholar
PubMed
Search for other papers by Simonetta Bianchi in
Google Scholar
PubMed
Search for other papers by Maria Grazia Tibiletti in
Google Scholar
PubMed
Search for other papers by Antonio Russo in
Google Scholar
PubMed
Search for other papers by Liliana Varesco in
Google Scholar
PubMed
Search for other papers by Gianluca Tedaldi in
Google Scholar
PubMed
Search for other papers by Bernardo Bonanni in
Google Scholar
PubMed
Search for other papers by Jacopo Azzollini in
Google Scholar
PubMed
Search for other papers by Siranoush Manoukian in
Google Scholar
PubMed
Search for other papers by Anna Coppa in
Google Scholar
PubMed
Search for other papers by Giuseppe Giannini in
Google Scholar
PubMed
Search for other papers by Laura Cortesi in
Google Scholar
PubMed
Search for other papers by Alessandra Viel in
Google Scholar
PubMed
Search for other papers by Marco Montagna in
Google Scholar
PubMed
Search for other papers by Paolo Peterlongo in
Google Scholar
PubMed
Search for other papers by Paolo Radice in
Google Scholar
PubMed
Search for other papers by Domenico Palli in
Google Scholar
PubMed
Search for other papers by Laura Ottini in
Google Scholar
PubMed
( 12 , 13 ). To date, only two studies have analyzed a possible role of CYP17A1 rs743572 in MBC risk, with contrasting results ( 14 , 15 ). A higher rs743572 CC genotype frequency among BRCA2 mutation carriers has been observed in a small MBC
Search for other papers by Xingyan Liu in
Google Scholar
PubMed
Search for other papers by Mei Xu in
Google Scholar
PubMed
Search for other papers by Min Qian in
Google Scholar
PubMed
Search for other papers by Lindong Yang in
Google Scholar
PubMed
). Polymorphisms of CYP17 T/C gene have been proved to result in increased synthesis of androgen and a higher risk of the development of several diseases, such as breast cancer ( 20 ), prostate cancer ( 21 ) and endometriosis ( 22 ) et al. , which was genotyped in
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Tomás P Griffin in
Google Scholar
PubMed
Search for other papers by Caroline M Joyce in
Google Scholar
PubMed
Search for other papers by Sumaya Alkanderi in
Google Scholar
PubMed
Search for other papers by Liam M Blake in
Google Scholar
PubMed
Search for other papers by Derek T O’Keeffe in
Google Scholar
PubMed
Search for other papers by Delia Bogdanet in
Google Scholar
PubMed
Department of Clinical Biochemistry, SUHCG, GUH, Galway, Ireland
Search for other papers by Md Nahidul Islam in
Google Scholar
PubMed
Lambe Institute for Translational Research, School of Medicine, NUIG, Galway, Ireland
Search for other papers by Michael C Dennedy in
Google Scholar
PubMed
Search for other papers by John E Gillan in
Google Scholar
PubMed
Search for other papers by John J Morrison in
Google Scholar
PubMed
Regenerative Medicine Institute at CÚRAM SFI Research Centre, School of Medicine, National University of Ireland Galway (NUIG), Galway, Ireland
Search for other papers by Timothy O’Brien in
Google Scholar
PubMed
Newcastle upon Tyne NHS Hospitals Foundation Trust, Newcastle upon Tyne, UK
NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK
Search for other papers by John A Sayer in
Google Scholar
PubMed
Search for other papers by Marcia Bell in
Google Scholar
PubMed
Search for other papers by Paula M O’Shea in
Google Scholar
PubMed
our familial screening program and was compound heterozygous for CYP24A1 variants: W275R and R439C. At his initial visit, II.1 had normal adj. Ca 2+ (2.46 mmol/L), 24,25(OH) 2 D (2.1 nmol/L) and iPTH (18 ng/L) and elevated 25(OH)D (148 nmol/L), 25
Search for other papers by Luigi Laino in
Google Scholar
PubMed
Search for other papers by Silvia Majore in
Google Scholar
PubMed
Search for other papers by Nicoletta Preziosi in
Google Scholar
PubMed
Search for other papers by Barbara Grammatico in
Google Scholar
PubMed
Search for other papers by Carmelilia De Bernardo in
Google Scholar
PubMed
Search for other papers by Salvatore Scommegna in
Google Scholar
PubMed
Search for other papers by Anna Maria Rapone in
Google Scholar
PubMed
Search for other papers by Giacinto Marrocco in
Google Scholar
PubMed
Search for other papers by Irene Bottillo in
Google Scholar
PubMed
Search for other papers by Paola Grammatico in
Google Scholar
PubMed
diagnostic approach for evaluation was conducted and psychological support was constantly provided to both patients and their families. The genetic analyses included the study of AR , AMH , CYP11B1 , CYP21A2 , DHH , DMRT1 , NR0B1 , NR5A1 , RSPO1